Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,372 | -10,310 | -1,402 | -609 | -1,111 |
| Depreciation Amortization | 132 | 45 | 0 | 1 | 2 |
| Accounts receivable | 32 | -77 | 34 | N/A | N/A |
| Other Working Capital | -388 | -521 | 727 | 807 | 361 |
| Other Operating Activity | 8,579 | 7,864 | 1,368 | 15 | 71 |
| Operating Cash Flow | $-4,016 | $-2,998 | $727 | $214 | $-677 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1,387 | 1,388 | N/A | N/A | N/A |
| Investing Cash Flow | $1,387 | $1,388 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 149 | 148 | N/A | N/A | N/A |
| Common Stock Issued | 465 | 146 | 347 | 1,389 | N/A |
| Other Financing Activity | 5,331 | 5,730 | 0 | 0 | 0 |
| Financing Cash Flow | $5,945 | $6,024 | $347 | $1,389 | $N/A |
| Exchange Rate Effect | -1 | N/A | N/A | 7 | -14 |
| Beginning Cash Position | 573 | 570 | 584 | 52 | 739 |
| End Cash Position | 3,887 | 4,983 | 287 | 1,661 | 49 |
| Net Cash Flow | $3,314 | $4,413 | $-297 | $1,610 | $-690 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,016 | -2,998 | 727 | 214 | -677 |
| Capital Expenditure | -6 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -4,022 | -2,998 | 727 | 214 | -677 |